A Novel RP-HPLC Method for Estimating Fulvestrant, Benzoyl Alcohol, and Benzyl Benzoate in Injection Formulation
- 1 Career Point University, CP Tower 1, IPIA, Kota, Rajasthan, India
- 2 HTS Bio Pharma, Aleap Industries Estate, Pragathi Nagar, Telangana, India
- 3 Sikkim Professional University, Gangtok, India
Abstract
For the quantitative determination of Fulvestrant, Benzyl alcohol, and Benzyl benzoate in Fulvestrant injection, an original RP-HPLC approach was developed. The gradient method was developed using HPLC and a Phenomenex Luna C8, 150 × 4.6 mm, i.d 3.0 μm particle size column with a gradient programme of mobile phases A and B. With a flow rate of 1.5 mL/minute, injection volume of 10 μL, and column temperature of 35°C, UV wavelength detection at 254 nm for Benzyl alcohol and Benzoyl Benzoate and 280 nm for Fulvestrant, mobile phase-A consists of DI water and mobile phase-B consists of Acetonitrile. The current study describes a single HPLC method for developing a Fulvestrant (Active), Benzyl alcohol (Cosolvent), and Benzyl Benzoate (Cosolvent) assay for Fulvestrant injection. The assay method was determined to be suitable for quantifying three components in the pharmaceutical product and was verified according to ICH guidelines.
- Balaram, V.M., Parmar, D., Teja, B.B., Rathnam, S., Rao, J.V. and Dasandi, B. (2010) Sensitive and Rapid High-Performance Liquid Chromatography Tandem Mass Spectrometry Method for Estimation of Fulvestrant in Rabbit Plasma. Biomedical Chromatography: BMC, 24, 863-867. https://doi.org/10.1002/bmc.1378
- Atila, A., Yilmaz, B. and Kadioglu, Y. (2016) Stability Indicating HPLC Method for the Determination of Fulvestrant in Pharmaceutical Formulation in Comparison with Linear Sweep Voltammetric Method. Iranian Journal of Pharmaceutical Research: IJPR, 15, 369-378.
- Thummaluru, R.R. and Gurrala, S. (2016) Development and Validation of HPLC-UV Method for the Estimation of Fulvestrant in Bulk Drug. Journal of Pharmacy Research, 10, 21-24.
- Ghosh, S., Mandal, S., Roy, T. and Ravikumar, B. (2021) A Novel RP—HPLC Analytical Method Development and Validation of Fulvestrant Injection as per ICH Guidelines. Egyptian Journal of Chemistry, 64, 2047-2055. https://doi.org/10.21608/ejchem.2021.56503.3215
- Dongala, T., Palakurthi, A.K., Vytla, Y., et al. (2019) A Novel UPLC-PDA Isocratic Method for the Quantification Fulvestrant in Oil-Based Pre-Filled Syringe Injection Matrix Formulations. Journal of Analytical Science and Technology, 10, Article No. 12. https://doi.org/10.1186/s40543-019-0171-7
- Addo, S., Yates, R.A. and Laight, A. (2002) A Phase I Trial to Assess the Pharmacology of the New Oestrogen Receptor Antagonist Fulvestrant on the Endometrium in Healthy Postmenopausal Volunteers. British Journal of Cancer, 87, 1354-1359. https://doi.org/10.1038/sj.bjc.6600644
- Bundred, N. and Howell, A. (2002) Fulvestrant (Faslodex): Current Status in the Therapy of Breast Cancer. Expert Review of Anticancer Therapy, 2, 151-160.
- Blackburn, S.A., Parks, R.M. and Cheung, K.L. (2018). Fulvestrant for the Treatment of Advanced Breast Cancer. Expert Review of Anticancer Therapy, 18, 619-628. https://doi.org/10.1080/14737140.2018.1473038
- Di Leo, A., Jerusalem, G. and Petruzelka, L. (2010) Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg with Fulvestrant 500 mg in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer. Journal of Clinical Oncology, 28, 4594-600. https://doi.org/10.1200/JCO.2010.28.8415
- Bogliolo, S., Gardella, B., Dominoni, M., Musacchi, V., Cassani, C., Zanellini, F., De Silvestri, A., Gaggero, C.R., Babilonti, L. and Spinillo, A. (2016) Effectiveness of Aromatase Inhibitors in the Treatment of Advanced Endometrial Adenocarcinoma. Archives of Gynecology and Obstetrics, 293, 701-708. https://doi.org/10.1007/s00404-015-3974-9